Mıstanoğlu Özatağ, D. Et Al. 2022. Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Treatment Results in Chronic Hepatitis C Patients Undergoing Hemodialysis. FLORA DERGİSİ , vol.1, no.4 , 736-741.

Mıstanoğlu Özatağ, D., Korkmaz, P., Çoşgun, S., & Konya, P., (2022). Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Treatment Results in Chronic Hepatitis C Patients Undergoing Hemodialysis. FLORA DERGİSİ , vol.1, no.4, 736-741.

Mıstanoğlu Özatağ, DURU Et Al. "Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Treatment Results in Chronic Hepatitis C Patients Undergoing Hemodialysis," FLORA DERGİSİ , vol.1, no.4, 736-741, 2022

Mıstanoğlu Özatağ, DURU M. Et Al. "Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Treatment Results in Chronic Hepatitis C Patients Undergoing Hemodialysis." FLORA DERGİSİ , vol.1, no.4, pp.736-741, 2022

Mıstanoğlu Özatağ, D. Et Al. (2022) . "Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Treatment Results in Chronic Hepatitis C Patients Undergoing Hemodialysis." FLORA DERGİSİ , vol.1, no.4, pp.736-741.

@article{article, author={DURU MISTANOĞLU ÖZATAĞ Et Al. }, title={Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir Treatment Results in Chronic Hepatitis C Patients Undergoing Hemodialysis}, journal={FLORA DERGİSİ}, year=2022, pages={736-741} }